Addressing asthma misdiagnosis in primary care
Co-authored by Dr. Andrew Potter, Whaddon Medical Centre
Metaverse or the office… What would you really prefer?
The metaverse, a digital universe combining virtual reality (VR) and augmented reality (AR) was supposed to transform the future of office work. However, that doesn’t seem to have happened (yet) Steve Jobs said “You’ve got to start with the customer experience and work backward to the technology. You can’t start with the technology then try to figure out where to sell it.”
Endomag is now part of Hologic
Hologic, Inc., a global leader in women’s health, has completed its previously announced acquisition of Endomagnetics Ltd (Endomag), for approximately $310 million.
Oxford-Cambridge region should be science ‘jewel’
Industry leaders have urged the government to make the Oxford-Cambridge region the “crown jewel” of European science and innovation.
The role of technology in respiratory care
In this episode Dr. Bipin Patel is joined by Dr. Andrew Potter, the GP lead at Whaddon Medical Centre, Milton Keynes Community Respiratory Service and the Milton Keynes Home Oxygen Assessment Service. Dr.
'Gene misbehaviour' widespread in healthy population
Scientists have uncovered that ‘gene misbehaviour’ – where genes are active when they were expected to be switched off – is a surprisingly common phenomenon in the healthy human population.
Empowering children and young people to become DNA heroes
D-CYPHR attended Leicester Grammar School STEM fair to highlight how every family can help childhood health research. Children and young people at the school have been involved in D-CYPHR for a while and it was a great chance to bring the project to life.
Clinic Pledge launches to help fertility patients juggle work and treatment
Patient charity Fertility Network has developed the ‘Fertility in the Workplace’ initiative to help employees and employers communicate better for mutual benefit. It is now looking at how IVF clinics can support working patients and is launching the Clinic Pledge – working with Bourn Hall, the world’s first IVF clinic, to demonstrate how it can be achieved.
Bailey Fisher welcomes Ludo Chapman as Non-Exec Chair
Bailey Fisher is pleased to announce the appointment of Ludo Chapman as Non-Executive Chair. Ludo brings a wealth of experience in driving business growth and fostering innovation, as a Founder, CEO and Chair/NED. He currently runs the Innovation Practice, and sits on the board of several high-growth companies.
Broken String Biosciences appoints Steve Becker as Chief Commercial Officer
Appointment brings extensive experience to lead commercial operations and accelerate growth in key global markets
SAS Advanced Analytics Hub launch
The Maxwell Centre and SAS, leaders in data and AI, jointly launch an AI & Advanced Analytics Hub to advance opportunities for the healthcare sector.
Kadans Science Partner commences work on new purpose-built wet lab facilities at Merlin Place, North Cambridge
New facilities adjacent to the Cambridge Science Park will comprise CL2 wet labs, dry labs and office space over six storeys
Bio-Rad outlines its advances leveraging droplet digital PCR in biopharma and translational research sectors
Strategic Collaborations in Molecular Residual Disease Monitoring of Cancer and Product Launches in ddPCR Portfolio Advance Corporate Strategy in H1 2024
Anthias teaching short courses at Pittcon 2025
Anthias Consulting are delighted to be delivering four training courses at Pittcon 2025, the world’s leading annual conference and exhibition on laboratory science, as part of the event's Short Course programme.
Metrion Biosciences appoints Dr Chris Mathes as Chief Commercial Officer
Appointment of experienced preclinical CRO specialist to support accelerated expansion into key global marketsCambridge, UK, 23 July 2024: Metrion Biosciences Ltd, the
Enterprise Therapeutics doses first person with Cystic Fibrosis in Phase 2 Trial for novel therapy ETD001
Trial aims to deliver clinical proof-of-concept and assess the safety profile of novel long acting ENaC inhibitor ETD001 ETD001, a CFTR
Lario Therapeutics awarded $6M Grant from The Michael J. Fox Foundation for Parkinson’s Research
Award supports preclinical research of Lario’s CaV2.3 calcium channel inhibitors as a novel disease-modifying approach for treatment of Parkinson's disease
Patients’ fun day to become annual event
A family fun day for young Addenbrooke’s patients was such a success it is to become an annual event.
BioResource participant samples used in research discovering major cause of IBD
BioResource volunteers have contributed to new research from The Francis Crick Institute - in collaboration with UCL and Imperial College London - which discovered a new biological pathway as the principal driver of Inflammatory Bowel Disease (IBD) and related conditions, and which can be targeted using existing drugs.
Regional experts step up fight against Hepatitis C
A team which is on a mission to eliminate hepatitis C virus (HCV/HepC) from the East of England by 2025 is launching another awareness campaign.
Ground-breaking study proves AI-driven programme has comparable effectiveness to human-delivered care while using up to 8 times fewer therapist hours
A new study by ieso Digital Health in collaboration with the and NIHR BioResource reveals that its AI-driven digital programme delivered results comparable to traditional human-led therapy for generalised anxiety. An estimated 1.2 million people in the UK are on waiting lists for NHS mental health services. Requiring up to eight times fewer therapist hours per patient, the ieso Digital Programme…
Research with CPFT finds AI can improve diagnosis of Alzheimer’s disease
Researchers at CPFT and the University of Cambridge have developed an artificial intelligence (AI) tool which outperforms clinical tests in predicting the progress of Alzheimer’s disease.